Education
About Us
Working with TipRanks
Follow Us
Uni-Bio Science Group Ltd. (HK:0690)
:0690
RESEARCH TOOLSreports
0690 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.05 - HK$0.14
Previous CloseN/A
Volume1.74M
Average Volume (3M)25.35M
Market Cap
HK$643.37M
Enterprise ValueHK$382.42M
Total Cash (Recent Filing)HK$183.90M
Total Debt (Recent Filing)HK$115.19M
Price to Earnings (P/E)8.0
Beta-0.12
Next Earnings
Sep 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 28, 2025Dividend Yield2.56%
Share Statistics
EPS (TTM)0.01
Shares Outstanding5,971,228,000
10 Day Avg. Volume10,511,199
30 Day Avg. Volume25,354,613
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)2.35
Price to Sales (P/S)0.00
P/FCF Ratio22.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Uni-Bio Science Group Ltd. News
PremiumCompany Announcements
Uni-Bio Science Group Secures Unanimous Shareholder Support at AGM
PremiumCompany Announcements
Uni-Bio Science Gains Approval for New Ophthalmology Product in China
PremiumCompany Announcements
Uni-Bio Science Group Achieves Record Profit and Expands Product Line
PremiumCompany Announcements
Uni-Bio Science Group Ltd. Declares Final Dividend for 2024PremiumCompany Announcements
Uni-Bio Science Group Announces New Board Composition0690 FAQ
What was Uni-Bio Science Group Ltd.’s price range in the past 12 months?
Uni-Bio Science Group Ltd. lowest stock price was HK$0.05 and its highest was HK$0.14 in the past 12 months.
What is Uni-Bio Science Group Ltd.’s market cap?
Uni-Bio Science Group Ltd.’s market cap is HK$643.37M.
When is Uni-Bio Science Group Ltd.’s upcoming earnings report date?
Uni-Bio Science Group Ltd.’s upcoming earnings report date is Sep 01, 2025 which is in 49 days.
How were Uni-Bio Science Group Ltd.’s earnings last quarter?
Uni-Bio Science Group Ltd. released its earnings results on Mar 27, 2025. The company reported HK$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.003.
Is Uni-Bio Science Group Ltd. overvalued?
According to Wall Street analysts Uni-Bio Science Group Ltd.’s price is currently Overvalued.
Does Uni-Bio Science Group Ltd. pay dividends?
Uni-Bio Science Group Ltd. pays a Notavailable dividend of HK$0.002 which represents an annual dividend yield of 2.56%. See more information on Uni-Bio Science Group Ltd. dividends here
What is Uni-Bio Science Group Ltd.’s EPS estimate?
Uni-Bio Science Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Uni-Bio Science Group Ltd. have?
Uni-Bio Science Group Ltd. has 5,971,228,000 shares outstanding.
What happened to Uni-Bio Science Group Ltd.’s price movement after its last earnings report?
Uni-Bio Science Group Ltd. reported an EPS of HK$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of Uni-Bio Science Group Ltd.?
Currently, no hedge funds are holding shares in HK:0690
Uni-Bio Science Group Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
92.85%
12-Months-Change
Fundamentals
Return on Equity
28.40%
Trailing 12-Months
Asset Growth
26.23%
Trailing 12-Months
Company Description
Uni-Bio Science Group Ltd.
Uni-Bio Science Group Ltd. (0690) is a biopharmaceutical company engaged in the research, development, and commercialization of innovative medications and biotechnology solutions. The company operates primarily in the sectors of pharmaceuticals and healthcare, focusing on the development of therapeutic products targeting diabetes, ophthalmology, and dermatology. Uni-Bio Science Group Ltd. aims to address unmet medical needs by providing high-quality and affordable healthcare solutions.
Technical Analysis
Sino Biopharmaceutical
―
Shanghai Fosun Pharmaceutical (Group) Co
―
China Resources Pharmaceutical Group Ltd.
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―